Document Detail


High factor VIII and the risk of venous thromboembolism.
MedLine Citation:
PMID:  12567199     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is now convincing evidence that a high level of coagulation factor VIII is an important risk factor for venous thromboembolism. A factor VIII plasma concentration above 1500 IU/l is associated with an almost 5-fold risk for a first episode of venous thrombosis. In thrombosis patients high factor VIII has been shown to persist over time and is not related to an acute phase reaction. High factor VIII is also an important risk factor for recurrence of venous thrombosis. In a prospective cohort study factor VIII levels exceeding the 90th percentile of the patient population conferred an almost 7-fold risk of recurrent venous thrombosis. The pathomechanisms leading to venous thrombosis in patients with high factor VIII are still unclear. In many patients, however, a biochemically detectable hypercoagulable state (as represented by elevated levels of the coagulation activation marker prothrombin thrombin fragment F1.2) was demonstrated. The optimal duration of secondary thromboprophylaxis for patients with high factor VIII levels is uncertain. We currently perform an interventional trial comparing conventional to extended anticoagulation. Reduction of factor VIII by administration of a non-selective ss-receptor blocker might be a promising therapeutic concept which is currently under investigation.
Authors:
Paul A Kyrle
Related Documents :
21397339 - Disease-associated inflammatory biomarker profiles in blood in different subtypes of mu...
15470279 - Combination of thrombophilia markers in acute myocardial infarction of the young.
21383629 - Generic abilhand questionnaire can measure manual ability across a variety of motor imp...
20713879 - Randomized, phase ii study of the insulin-like growth factor-1 receptor inhibitor imc-a...
2837699 - Angiotensin converting enzyme inhibitors and cough.
8141119 - Continuous infusion of monoclonal antibody-purified factor viii: rational approach to s...
24200869 - The relationship between fear of falling to spatiotemporal gait parameters measured by ...
3329519 - Angioimmunoblastic lymphadenopathy with dysproteinemia in thailand.
6768239 - Unusual radiographic findings in adult pulmonary tuberculosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hämostaseologie     Volume:  23     ISSN:  0720-9355     ISO Abbreviation:  Hamostaseologie     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-04     Completed Date:  2003-03-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8204531     Medline TA:  Hamostaseologie     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  41-4     Citation Subset:  IM    
Affiliation:
Department of Hematology and Hemostasis, Vienna Medical School, Austria. paul.kyrle@akh-wein.ac.at
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Factor VIII / metabolism*
Humans
Recurrence
Risk Factors
Thromboembolism / epidemiology*,  etiology
Venous Thrombosis / epidemiology*,  etiology
Chemical
Reg. No./Substance:
9001-27-8/Factor VIII

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variation...
Next Document:  Perspectives of eating disorders from the Charité Hospital in Berlin.